UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549

INFORMATION REQUIREMENTS FOR FILINGS UPON ACQUISITION OF FIVE PERCENT OF A CLASS
OF EQUITY SECURITIES SUBJECT TO THE REPORTING REQUIREMENTS OF THE 1934 ACT


                                  SCHEDULE 13D

                        Under the Securities Act of 1934



                         Surgical Safety Products, Inc.
                             (Exact name of Issuer)

                         COMMON STOCK, $0.001 par value
                         (Title of Class of Securities)

                                    868906108
                                 (CUSIP Number)

With a copy to:

     Surgical Safety Products, Inc.              Mintmire & Associates
     3665 Bee Ridge Road, Suite 300              265 Sunrise Ave., Suite 204
     Sarasota, Florida  34233                    Palm Beach, FL  33480
     (941) 927-7874                              (561) 832-5696
                           --------------------------
                  (Name, Address and Telephone Number of Person
                Authorized to Receive Notices and Communications)

                                  October 2001
             (Date of Event which Requires Filing of the Statement)



     If the filing  person has  previously  filed a statement on Schedule 13G to
report the acquisition  which is the subject of this Schedule 13D, and is filing
this schedule because of Rule 13d-1(b)(3) or (4), check the following box 9.








- -----------------------------------------------------------------------------
(1)  Names of Reporting Persons.  S.S. or I.R.S.  Identification Number of Above
     Persons

         William P.  Danielczyk
- -----------------------------------------------------------------------------

(2)  Check the Appropriate Box if a Member       (a)______________________
     of a Group (See Instructions)               (b)__________X___________
- ------------------------------------------------------------------------------

(3)  SEC Use Only

- -----------------------------------------------------------------------------
(4)  Source of Funds (See Instructions)

                                       SC
- ----------------------------------------------------------------------------

(5)  Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d)
     or 2(e)

                                        9
- ----------------------------------------------------------------------------

(6)  Citizenship of Place of Organization:    Florida, USA

- ----------------------------------------------------------------------------

Number of Shares              (7)  Sole Voting Power              6,218,134
Beneficially Owned
by Each Reporting
Person With                   (8)  Shared Voting Power                    0


                              (9) Sole Dispositive Power          6,218,134


                              (10) Shared Dispositive Power               0

- ------------------------------------------------------------------------------

(11) Aggregate Amount Beneficially Owned by Each Reporting Person

                                   6,218,134

- ------------------------------------------------------------------------------

(12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares*

- ------------------------------------------------------------------------------







(13) Percent of Class Represented by Amount in Row (11)

                                     15.53%

- ------------------------------------------------------------------------------

(14) Type of Reporting Person (See Instructions)*

                                       IN

- ------------------------------------------------------------------------------
Item 1. Security and Issuer

This  Schedule  13D relates to the common  stock,  $0.001 par value (the "Common
Stock"),  of  Surgical  Safety  Products,  Inc.,  a New  York  corporation  (the
"Company"),  whose  principal  executive  offices  are located at 3665 Bee Ridge
Road, Suite 300, Sarasota, Florida 34233

Item 2.           Identity and Background

(a)  William P. Danielczyk

(b)  9813 Godwin Drive, Manassas, VA   20110

(c)  Director

(d) and (e).  During the past five years,  neither the Reporting  Person nor any
person  listed on  Schedule  A has been  convicted  in any  criminal  proceeding
(excluding  traffic  violations  or similar  misdemeanors)  or been a party to a
civil proceeding of a judicial or administrative body of competent  jurisdiction
and as a result of such  proceeding  was or is subject to a judgment,  decree or
final  order  enjoining  future  violations  of,  or  prohibiting  or  mandating
activities  subject to, federal or state securities law or finding any violation
with respect to such laws.

(f)  USA

Item 3. Sources and Amount of Funds or Other Consideration

The  consideration  used to purchase  the common stock were all of the shares of
Surgical Safety Products,  Inc., a New York  corporation,  held by the Reporting
Person,  pursuant  to the terms of a certain  Agreement  and Plan of Merger  and
Reorganization, dated as of October 2001, Surgical Safety Products, Inc.and OIX,
INC. ("OIX"), a Florida corporation and wholly owned subsidiary of Company, and,
C5 Health,  Inc. ("C5"),  a Delaware  corporation,  shareholders,  including the
Reporting Person, William P. Danielczyk (the "Stock Exchange Agreement")

Item 4. Purpose of Transaction

The  Reporting  Person has acquired  the shares of Common  Stock for  investment
purposes only.

(a) Not applicable

(b) As a result of the Plan of Merger and  Reorganization  and the  transactions
contemplated  in that  Ageement,  the Reporting  Person  together with the other
Surgical  Safety  Products,  Inc.  shareholders  named  in Item 5  below  became
controlling shareholders in the Company and Surgical Safety Products, Inc.






(c) Not applicable

(d) In  accordance  with the terms  and  conditions  of the Plan of  Merger  and
Reorganization,  new  members  of the board of  directors  of the  Company  were
elected and new officers were appointed. The directors of the Company are Dr. G.
Michael Swor,  David Swor,  Jim Stuart William P.  Danielczyk,  R. Paul Gray and
Robert Lyles. The officers of the Company are William P. Danielczyk as Chairman,
Dr. G. Michael Swor as Vice Chairman,  Timothy S. Novak as President and R. Paul
Gray as Secretary and Treasurer of the Company.

(e) through (j) Not applicable

Item 5. Interest in Securities of Issuer

(a) and (b) William P. Danielczyk is the beneficial owner of 6,218,134 shares of
Common  Stock,  which shares  represent  approximately  15.53% of the issued and
outstanding  shares of Common Stock,  and has sole voting and dispositive  power
with respect to 6,218,134 shares of Common Stock. Timothy Novak may be deemed to
be the  beneficial  owner of  5,442,432  shares of Common  Stock,  which  shares
represent  approximately  13.59% of the issued and outstanding  shares of Common
Stock, and as such, may be deemed to have sole voting and dispositive power with
respect to 5,442,432  shares of Common Stock.  Dr. G. Michael Swor may be deemed
to be the  beneficial  owner of 6,608,945  shares of Common Stock,  which shares
represent  approximately  16.50% of the issued and outstanding  shares of Common
Stock,  and has sole  voting and  dispositive  power with  respect to  6,608,945
shares of Common Stock. Together William P. Danielczyk, Timothy Novak and Dr. G.
Michael Swor  beneficially own 18,269,511  shares of Common Stock,  which shares
represent  45.62% of the issued and  outstanding  shares of Common  Stock of the
Company. William P. Danielczyk, Timothy Novak and Dr. G. Michael Swor are of the
view that they are not acting as a "group" for purposes of Section  13(d) of the
Securities  Exchange  Act of 1934 and that they are not  otherwise  required  to
attribute to each other the "beneficial  ownership" of securities held by any of
them.

(c) To the best knowledge of the Reporting Person,  neither the Reporting Person
nor any persons  named in response to paragraph  (a) nor any person set forth in
Schedule A, has effected any transaction in Company Common Stock during the past
60 days, except as disclosed herein.

(d) and (e) Not applicable.

The number shares  beneficially owned by the Reporting Person and the percentage
of outstanding shares represented thereby are based on the number of outstanding
shares as disclosed by the Reporting Person, an officer of the Company.

Item 6. Contracts,  Arrangements,  Understandings, or Relationships with Respect
        to Securities of Issuer

         None





Item 7. Material to Be Filed as Exhibits

The  Agreement and Plan of Merger and  Reorganization  dated as of October 2001,
among Surgical Safety Products, Inc.and OIX, INC. ("OIX"), a Florida corporation
and wholly owned subsidiary of Company,  and, C5 Health, Inc. ("C5"), a Delaware
corporation, under which the Reporting Person acquired the shares has been filed
as an Exhibit to the Form 8K reporting the event.  Such exhibit is  incorporated
by reference herein.





                                   SIGNATURES

         After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.


Date:11/12/2001

                              /s/ William P. Danielczyk
                           ---------------------------------------
                           William P. Danielczyk